CAClaude Aguergaray

Claude Aguergaray

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Claude Aguergaray has a total of 71 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Shining a light on brain tumors: a review of Raman spectroscopy in the operating room

    by Samuel Cutfield, Katherine Ember, Clinton Turner, Jason Correia, Kevin Petrecca, Michel Nieuwoudt, Michael Dragunow, Claude Aguergaray, Frédéric Leblond

    SignificanceMaximizing brain tumor resection while preserving neurological function remains a neurosurgical challenge. Current intraoperative tools, including MRI, ultrasound, and frozen section, disrupt workflow and provide limited real-time molecular information.AimThis review synthesizes evidence for Raman spectroscopy as an intraoperative tool in glioma and brain metastasis surgery, comparing it against established alternatives and framing findings within a diagnostic hierarchy from analytic validity through clinical utility to outcome benefit.ApproachEvidence is arranged by surgical setting: in vivo handheld fiber-optic probes and ex vivo platforms including Raman microscopy, stimulated Raman scattering (SRS) imaging, and visible resonance Raman.ResultsIn vivo multicenter studies report >85% per-measurement sensitivity and specificity for tumor versus normal classification, with nondestructive analysis in ∼2 s. Molecular marker detection, including IDH mutation status, has been demonstrated predominantly ex vivo. Ex vivo SRS generates histology-quality images and can classify selected molecular alterations within ∼90 s, though this molecular capability is not clinically validated.ConclusionsWhile multicenter studies support the analytic validity of Raman-based tissue detection, clinical adoption requires prospective outcome trials, standardized acquisition protocols, and regulatory advancement.

  • High-sensitivity Raman spectroscopy for prostate cancer detection and tissue extraction guidance

    by Max J. Dooley, Hanlin Li, Irene Low, Mary L. Christie, Morgan R. Pokorny, Ariane Araquel-Lacamiento, Alex Porter, Kamran Zargar-Shoshtari, Claude Aguergaray

    This study presents classification models trained to diagnose and grade prostate cancer using fresh prostate biopsies. We compare the performance of classification models with optimised sensitivity and specificity (standard models) with application-specific models designed to maximise sensitivity and negative predictive value (NPV). Standard models achieve 80% sensitivity and 81% specificity. Application-specific models, calibrated to 90% sensitivity and 95% NPV, are intended to provide clinicians with a tool they can use with confidence to support intraoperative decisions, specifically to improve tissue retention during biopsy procedures and to ensure clear surgical margins. To this end, we introduce a 5-layer algorithm that combines 5 application-specific models chosen for overall best performance. This algorithm can reduce the number of biopsy samples required for diagnosis by 47% while maintaining 90% sensitivity, 95% NPV, and 62% specificity. All models are independently validated using two large patient cohorts. These results support the targeted use of Raman spectroscopy for real-time tissue analysis in diagnostic and intraoperative settings. The technology’s clinical value as a decision-support tool aligns with the shared goal of pathologists and urologists to reduce the number of prostate biopsy cores while maintaining high sensitivity for clinically significant cancer. Prior studies have improved biopsy efficiency, but their performance has been variable, and concerns remain regarding underdetection of significant disease, revealing the need for approaches that improve biopsy efficiency without increasing diagnostic risk. The technology described here provides a realistic solution for targeted biopsy guidance to support more precise and evidence-based clinical decisions.

  • Towards high-power MOPA architectures in single-mode fibers for mid-IR mode-locked operation

    by Bhaswar Dutta Gupta, Stanley Tang, Thibaud Berthelot, Solenn Cozic, Samuel Poulain, Claude Aguergaray

    We report on a master oscillator power amplifier (MOPA) system at 2.8 µm to achieve an average power of 10.28 W with a pulse energy and peak power of 403 nJ and 5.76 kW, respectively. The seed, a semiconductor saturable mirror (SESAM) based mode-locked linear cavity source, delivers approximately 70 ps pulses at 28.16 MHz. Two amplifier stages are utilized in counter-pumping and dual-pumping configurations to enable high extraction efficiency and signal gain. To the best of our knowledge, this result is the highest average power and pulse energy obtained from a SESAM-based 2.8 µm mode-locked laser employing ZBLAN fiber MOPA architecture. It paves the way for achieving high average power in-fiber nonlinear amplification in single-mode fibers in the mid-infrared wavelength region.


  • Open Access

    Raman spectroscopy and mass spectrometry identifies a unique group of epidermal lipids in active discoid lupus erythematosus

    by Hannah U Holtkamp, Claude Aguergaray, Kalita Prangnell, Christopher Pook, Satya Amirapu, Angus Grey, Cather Simpson, Michel Nieuwoudt, Paul Jarrett

    Discoid lupus erythematosus (DLE) is the most common form of cutaneous lupus1. It can cause permanent scarring. The pathophysiology of is not fully understood. Plasmacytoid dendritic cells are found in close association with apoptotic keratinocytes inferring close cellular signalling. Matrix Associated Laser Desorption Ionisation (MALDI) combined with Fourier Transform Ion Cyclotron Resonance Mass Spectrometry (FT-ICR-MS) is an exquisitely sensitive combination to examine disease processes at the cellular and molecular level. Active areas of discoid lupus erythematosus were compared with normal perilesional skin using MALDI combined with FT-ICR-MS. A unique set of biomarkers, including epidermal lipids is identified in active discoid lupus. These were assigned as sphingomyelins, phospholipids and ceramides. Additionally, increased levels of proteins from the keratin, and small proline rich family, and aromatic amino acids (tryptophan, phenylalanine, and tyrosine) in the epidermis are observed. These techniques, applied to punch biopsies of the skin, have shown a distinctive lipid profile of active discoid lupus. This profile may indicate specific lipid signalling pathways. Lipid rich microdomains (known as lipid rafts) are involved in cell signalling and lipid abnormalities have been described with systemic lupus erythematosus which correlate with disease activity.


  • Open Access

    Portable System for In-Clinic Differentiation of Skin Cancers from Benign Skin Lesions and Inflammatory Dermatoses

    by Michel Nieuwoudt, Paul Jarrett, Hannah Matthews, Michelle Locke, Marco Bonesi, Brydon Burnett, Hannah Holtkamp, Claude Aguergaray, Ira Mautner, Thom Minnee, et al.


  • Open Access

    Raman spectroscopy system for real‐time diagnosis of clinically significant prostate cancer tissue

    by Suse J. van Breugel, Irene Low, Mary L. Christie, Morgan R. Pokorny, Ramya Nagarajan, Hannah U. Holtkamp, Komal Srinivasa, Satya Amirapu, Michel K. Nieuwoudt, M. Cather Simpson, et al.

    Prostate cancer (PCa) is a significant healthcare problem worldwide. Current diagnosis and treatment methods are limited by a lack of precise in vivo tissue analysis methods. Real‐time cancer identification and grading could dramatically improve current protocols. Here, we report the testing of a thin optical probe using Raman spectroscopy (RS) and classification methods to detect and grade PCa accurately in real‐time. We present the first clinical trial on fresh ex vivo biopsy cores from an 84 patient cohort. Findings from 2395 spectra measured on 599 biopsy cores show high accuracy for diagnosing and grading PCa. We can detect clinically significant PCa from benign and clinically insignificant PCa with 90% sensitivity and 80.2% specificity. We also demonstrate the ability to differentiate cancer grades with 90% sensitivity and specificity ≥82.8%. This work demonstrates the utility of RS for real‐time PCa detection and grading during routine transrectal biopsy appointments.


  • Modeling of mode-locked fiber lasers and amplifiers with accurate saturable gain evaluation

    by Bhaswar Dutta Gupta, Ian Hendry, Stanley Tang, Thibaud Berthelot, Paul Du Teilleul, Solenn Cozic, Samuel Poulain, Miro Erkintalo, Claude Aguergaray

    We present a numerical model for mode-locked lasers and ultrafast nonlinear amplifiers in which the saturated gain profiles along active fibers are judiciously computed using experimental pump powers as input. This eliminates the need for approximating the gain profile by using a small-signal gain coefficient and saturation energy to simulate pulse propagation in active fibers. Our model shows good agreement with experiments involving mode-locked cavities at 1 µm with a silica glass host doped with ytterbium ions. Accurate results are also obtained for continuous-wave and mode-locked laser cavities around 2.8 µm, which uses ZBLAN fiber doped with erbium ions. In the case of Er:ZBLAN fiber, we use the model to show regions of stable mode-locking delivering a single pulse as output and how the spectral width changes with variation in doping concentration and fiber lengths. Our model enables accurate numerical modeling of mode-locked fiber lasers and ultrafast amplifiers, and can be useful in guiding the design of new architectures, understanding complex intracavity laser dynamics, and optimizing device output.


  • Accurate modelling of mode-locked dynamics in fibre lasers

    by Bhaswar Dutta Gupta, Miro Erkintalo, Claude Aguergaray

    We present a comprehensive numerical mode-locked laser model that incorporates amplified spontaneous emission and demonstrates significantly improved agreement with experimental results. Pump powers, which are the only input parameters, are also accurately predicted.

  • The combination of Raman spectroscopy and mass spectrometry to investigate cutaneous metallosis

    by Jenny G. Chung, Hannah Holtkamp, Michel Nieuwoudt, Hannah Matthews, Claude Aguergaray, Stuart Morrow, Michael Caughey, Natalie Poppito, Paul Jarrett


  • Bessel beams increase the efficiency of femtosecond laser ablation of bone

    by Cather Simpson, Simon Ashforth, Claude Aguergaray

    There is no online version at this time. The PDF is only available to people who have bought the paper or have a subscription.